These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2597222)

  • 21. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content.
    Camejo G; López A; López F; Quiñones J
    Atherosclerosis; 1985 Apr; 55(1):93-105. PubMed ID: 4004985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans.
    Anber V; Griffin BA; McConnell M; Packard CJ; Shepherd J
    Atherosclerosis; 1996 Aug; 124(2):261-71. PubMed ID: 8830938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis.
    Camejo G; Hurt-Camejo E; Wiklund O; Bondjers G
    Atherosclerosis; 1998 Aug; 139(2):205-22. PubMed ID: 9712326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The dynamic change of extracellular matrix in human coronary atherogenesis].
    Yang F; Zhao P; She M
    Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):177-81. PubMed ID: 11244976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans.
    Fagerberg B; Wiklund O; Agewall S; Camejo G; Wikstrand RJ
    Eur J Clin Invest; 1996 Nov; 26(11):960-5. PubMed ID: 8957200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidized LDL binding to a macrophage-secreted extracellular matrix.
    Kaplan M; Aviram M
    Biochem Biophys Res Commun; 1997 Aug; 237(2):271-6. PubMed ID: 9268699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
    Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
    J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and properties of a lipoprotein-complexing proteoglycan from human aorta.
    Camejo G; Lalaguna F; López F; Starosta R
    Atherosclerosis; 1980 Mar; 35(3):307-20. PubMed ID: 7362702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the chondroitin sulfate proteoglycans of amyloid precursor (appican) and amyloid precursor-like protein 2.
    Pangalos MN; Shioi J; Robakis NK
    J Neurochem; 1995 Aug; 65(2):762-9. PubMed ID: 7616233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of olive and sunflower oils on low density lipoprotein level, composition, size, oxidation and interaction with arterial proteoglycans.
    Carmena R; Ascaso JF; Camejo G; Varela G; Hurt-Camejo E; Ordovas JM; Martinez-Valls J; Bergstöm M; Wallin B
    Atherosclerosis; 1996 Sep; 125(2):243-55. PubMed ID: 8842355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of a proteoglycan variant from human aorta exhibiting a marked affinity for low density lipoprotein and demonstration of its enhanced expression in atherosclerotic plaques.
    Vijayagopal P; Figueroa JE; Fontenot JD; Glancy DL
    Atherosclerosis; 1996 Dec; 127(2):195-203. PubMed ID: 9125309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human arterial proteoglycans increase the rate of proteolytic fusion of low density lipoprotein particles.
    Pentikäinen MO; Lehtonen EM; Oörni K; Lusa S; Somerharju P; Jauhiainen M; Kovanen PT
    J Biol Chem; 1997 Oct; 272(40):25283-8. PubMed ID: 9312145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
    Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of low density lipoprotein association with the arterial intima. A possible environment for the antiatherogenic action of beta-blockers.
    Camejo G; Hurt E; Thubrikar M; Bondjers G
    Circulation; 1991 Dec; 84(6 Suppl):VI17-22. PubMed ID: 1683606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes.
    Davidsson P; Hulthe J; Fagerberg B; Olsson BM; Hallberg C; Dahllöf B; Camejo G
    J Lipid Res; 2005 Sep; 46(9):1999-2006. PubMed ID: 15995172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of a synthetic apolipoprotein B-100 peptide and peptide analogues to chondroitin 6-sulfate: effects of the lipid environment.
    Olsson U; Camejo G; Bondjers G
    Biochemistry; 1993 Feb; 32(7):1858-65. PubMed ID: 8439543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basement membrane chondroitin sulfate proteoglycans: localization in adult rat tissues.
    McCarthy KJ; Couchman JR
    J Histochem Cytochem; 1990 Oct; 38(10):1479-86. PubMed ID: 2401786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varied low density lipoprotein binding property of proteoglycans synthesized by vascular smooth muscle cells cultured on extracellular matrix.
    Vijayagopal P; Menon PV
    Atherosclerosis; 2005 Jan; 178(1):75-82. PubMed ID: 15585203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDL2 interferes with LDL association with arterial proteoglycans: a possible athero-protective effect.
    Umaerus M; Rosengren B; Fagerberg B; Hurt-Camejo E; Camejo G
    Atherosclerosis; 2012 Nov; 225(1):115-20. PubMed ID: 22999079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.